Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Ordinary Shares, par value GBP 0.003 per share
-
Shares outstanding
-
792,553,191
-
Total 13F shares
-
105,735,860
-
Share change
-
+5,237,107
-
Total reported value
-
$434,698,726
-
Put/Call ratio
-
230%
-
Price per share
-
$4.11
-
Number of holders
-
76
-
Value change
-
+$21,814,008
-
Number of buys
-
29
-
Number of sells
-
32
Institutional Holders of Mereo BioPharma Group plc - Ordinary Shares, par value GBP 0.003 per share (MREO) as of Q3 2024
As of 30 Sep 2024,
Mereo BioPharma Group plc - Ordinary Shares, par value GBP 0.003 per share (MREO) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
105,735,860 shares.
The largest 10 holders included
Rubric Capital Management LP, JANUS HENDERSON GROUP PLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Rock Springs Capital Management LP, MANGROVE PARTNERS IM, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), MILLENNIUM MANAGEMENT LLC, Frazier Life Sciences Management, L.P., 683 Capital Management, LLC, and ALKEON CAPITAL MANAGEMENT LLC.
This page lists
76
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.